M&A Synergies Drive BSX: Is it Worth Buying the Stock Now? - MSN

Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently traded above $94.00 per share, closing at $95.65 yesterday.

$94.00
OFF

M&A Synergies Drive BSX: Is It Worth Buying The Stock Now? - MSN

2 weeks from now

Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently traded above $94.00 per share, closing at $95.65 yesterday.

msn.com

1%
OFF

Reasons To Retain BSX Stock In Your Portfolio For Now

2 weeks from now

Nov 19, 2024 · In the past year, this Zacks Rank #3 (Hold) company’s shares have rallied 66.1% compared with the industry’s 21.4% growth and the S&P 500 composite’s 29.2% gain.

yahoo.com

1%
OFF

Here's Why You Should Buy Boston Scientific (BSX) Stock Now

2 weeks from now

In the past year, this Zacks Rank #2 (Buy) stock has rallied 48.1% compared with the 3.8% rise of the industry and the 26.1% growth of the S&P 500 composite.

msn.com

1%
OFF

Looking For A Growth Stock? 3 Reasons Why Boston Scientific

2 weeks from now

Oct 31, 2024 · Right now, year-over-year cash flow growth for Boston Scientific is 14.1%, which is higher than many of its peers. In fact, the rate compares to the industry average of -14.7%.

nasdaq.com

$94.00
OFF

M&A Synergies Drive BSX: Is It Worth Buying The Stock Now?

2 weeks from now

14 hours ago · Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently traded above $94.00 per share, closing at …

nasdaq.com

20%
OFF

Why Boston Scientific (BSX) Is A Top Growth Stock For The Long-Term

2 weeks from now

Nov 1, 2024 · BSX sits at a Zacks Rank #2 (Buy), holds a Growth Style Score of B, and has a VGM Score of B. Earnings and sales are forecasted to increase 20% and 16.4% year-over …

yahoo.com

1%
OFF

Here's Why You Should Add BSX Stock To Your Portfolio Now

2 weeks from now

Oct 2, 2024 · The renowned manufacturer of medical devices and products has a market capitalization of $123.41 billion. BSX has an estimated earnings growth rate of 17.1% for 2024 …

nasdaq.com

177%
OFF

Boston Scientific Standing Apart As A Rare Med-Tech Growth Story

2 weeks from now

1 day ago · Boston Scientific’s Farapulse is the early leader in the field, and it has driven some eye-popping numbers in recent quarters, with electrophysiology (or EP) growth of 177% in …

seekingalpha.com

1%
OFF

Here's Why You Should Invest In Boston Scientific (BSX) Now

2 weeks from now

Feb 8, 2024 · Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance. ... (Buy) stock has gained 37.1% compared with a 5.5% fall of …

zacks.com

62%
OFF

Boston Scientific Stock Price Forecast. Should You Buy BSX?

2 weeks from now

6 days ago · Buy or Hold candidate since Jan 03, 2025 Gain 4.62%. The Boston Scientific Corporation stock price fell by -1.12% on the last day (Friday, 10th Jan 2025) from $95.95 to …

stockinvest.us

1%
OFF

Looking For A Growth Stock? 3 Reasons Why Boston Scientific …

2 weeks from now

Oct 31, 2024 · Right now, year-over-year cash flow growth for Boston Scientific is 14.1%, which is higher than many of its peers. In fact, the rate compares to the industry average of -14.7%.

zacks.com

FAQs about M&A Synergies Drive BSX: Is it Worth Buying the Stock Now? - MSN Coupon?

What makes Boston Scientific BSX a strong company?

Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by its category leadership strategy, which is fueled by innovation, clinical evidence generation and the strong execution power of the global team. ...

Should you buy BSX (BSX)?

BSX sits at a Zacks Rank #2 (Buy), holds a Growth Style Score of B, and has a VGM Score of B. Earnings and sales are forecasted to increase 20% and 16.4% year-over-year, respectively. 12 analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.06 to $2.46 per share for 2024. ...

Is Boston Scientific (BSX) a rare med-tech growth story?

Boston Scientific Standing Apart As A Rare Med-Tech Growth Story Jan. 14, 2025 2:52 PM ETBoston Scientific Corporation (BSX) StockABT, JNJ, MDT1 Like Stephen Simpson 20.14KFollowers Follow Play(14min) Summary ...

Did BSX beat on earnings?

BSX beat on earnings in each of the trailing four quarters, delivering an average surprise of 8.29%. Let’s delve deeper. Impressive Value-Adding Acquisitions: Boston Scientific’s impressive recent acquisitions have added numerous products with immense potential. ...

Will BSX buy bolt medical?

This is just shy of the company’s 52-week high of $97.13 reached on Jan. 8 following the company’s announcement of entering into a definitive agreement to acquire Bolt Medical, Inc. — an intravascular lithotripsy (IVL) advanced laser-based platform developer. The market seems to be encouraged by this strategic move by BSX. ...

Is BSX a good stock to buy in Q4?

Since then, the company’s outperformance has pulled the average full-year estimate up to $16.6B and BSX has been at the top of the list when it comes to large cap growth within med-tech. I believe there’s still some upside in Q4. ...